Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jonathan Wallis

Newcastle AuthorsTitleYearFull text
Erhan Aptullahoglu
Mohammed Howladar
Dr Jonathan Wallis
Dr Helen Marr
Professor Julie Irving
et al.		Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating TP53 Wild-Type Chronic Lymphocytic Leukemia2025
Erhan Aptullahoglu
Dr Sirintra Nakjang
Dr Jonathan Wallis
Dr Helen Marr
Dr Scott Marshall
et al.		RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia2024
Erhan Aptullahoglu
Dr Jonathan Wallis
Dr Helen Marr
Dr Elaine Willmore
Professor John Lunec
SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia2023
Dr Evan Mulligan
Dr Susan Tudhope
Dr Jill Hunter
Sarah Elliott
Dr Jonathan Wallis
et al.		Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling2023
Dr Carmela Ciardullo
Dr Jonathan Wallis
Dr Helen Marr
Dr Nicholas Bown
Dr Elaine Willmore
et al.		Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition2023
Dr Timothy Barrow
Dr Sirintra Nakjang
Kateryna Bilotkach
Dr Laura Woodhouse
Gesa Junge
et al.		Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia2021
Eoin Moloney
Dr Joy Allen
Dr Peter Carey
Dr Louise Johnston
Rachel O'Leary
et al.		Efficiency and Health Economic Evaluations of BD OneFlow™ Flow Cytometry Reagents for Diagnosing Chronic Lymphoid Leukemia2019
Dr Carmela Ciardullo
Erhan Aptullahoglu
Dr Laura Woodhouse
Dr Wei-Yu Lin
Dr Jonathan Wallis
et al.		Non-genotoxic MDM2 inhibition selectively induces pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells2019
Dr Jonathan Wallis
A transfusion prescription template and other human factor interventions to improve balanced transfusion delivery in major haemorrhage due to trauma2018
Dr Jonathan Wallis
Age of platelet concentrates and time to the next transfusion2018
Dr Timothy Barrow
Dr Laura Woodhouse
Gesa Junge
Dr Susan Tudhope
Dr Jonathan Wallis
et al.		The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy2016
Professor Andrew Gennery
Dr Jonathan Wallis
ABO-incompatible cardiac transplantation in pediatric patients with high isohemagglutinin titers2015
Dr Elaine Willmore
Dr Aaron Ions Gardner
Dr Susan Tudhope
Belinda Murtani
Jessica Caffry
et al.		Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells2015
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Morton
et al.		PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Dr Jonathan Wallis
Variant CJD and blood transfusion2015
12345